The Boyden chamber invasion assay showed that LIMK1 or CDK5 overexpression enhanced ESCC cell invasion, while knockdown or knockout of β‐catenin by shRNA or sgRNA significantly abrogated these effects (Figure 6B; Figure S7C, Supporting Information). The gene discussed is CDK5; the disease is esophageal squamous cell carcinoma.